Newron Pharmaceuticals S.P.A. v The Comptroller General of Patents, Trademarks and Designs

Core Citations

CONSIDERS

• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents

REFERS TO

• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
• Abraxis Bioscience LLC v The Comptroller-General of Patents
• Yeda Research and Development Company Ltd v Comptroller General of Patents

[See more]

• Draco AB's SPC Application

This document cites

• Abraxis Bioscience LLC v The Comptroller-General of Patents
• Yeda Research and Development Company Ltd v Comptroller General of Patents
• Draco AB's SPC Application
• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.



See all quotations

• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products